Skip to main content

FULL MENU FULL MENU

Federal Practitioner Home
Digital Edition/App

Breast Cancer
ClinicalEdge
Colon and Rectal
Education Center
Immuno-oncology
Prostate Cancer
Rare Diseases

Clinical Topics & News

Thyroid Lymphoma

Fed Pract. 2013 February;30(2):16

Author(s):

Chin H

Author and Disclosure Information

Hong Chin, MD, PhD; Michael Baumann, MD; Nosrat Hillman, MD; and Reba Crowell, RN, NP

Primary thyroid lymphoma is an uncommon cancer and includes

Read the Full Article

Recommended Reading

Neutropenia and the White Blood Cells

Protecting Patients with HCV from Lymphoma

Burkitt Lymphoma Presenting as Thoracic Back Pain

Psoriasis: The Lymphoma Link

Lymphoma & Plasma Cell Disorders

Clinical Topics

Evaluating the Incidence of Febrile Neutropenia and the Appropriate Use of Prophylactic Granulocyte Colony Stimulating Factors in Veterans Who Received Treatment for Non- Hodgkin’s Lymphoma
Publish date: September 2, 2022
A Rare Case of HHV8+ Multicentric Castleman Disease Presenting as Dermatitis
Nodular Sclerosing Hodgkin Lymphoma With Paraneoplastic Cerebellar Degeneration
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
Publish date: June 24, 2022
FDA withdraws lymphoma drug approval after investigation
Publish date: June 1, 2022

Digital Edition

AVAHO 2021 Meeting Posters and Abstracts
Publish date: September 22, 2021
Advances in Hematology and Oncology
Publish date: September 3, 2021
Advances in Hematology and Oncology
Publish date: May 20, 2021
August 2020 Advances in Precision Oncology
Abstracts Presented at the 2020 AVAHO Annual Meeting (Digital Edition)

Multimedia

Experts break down latest CAR T-cell advances in lymphoma
Publish date: January 22, 2020
SC daratumumab deemed feasible for every multiple myeloma patient
Publish date: July 11, 2019
Creating CAR T-cell therapies for T-cell malignancies
Publish date: April 16, 2019

Conference Coverage

Multiprong strategy makes clinical trials less White
Publish date: June 23, 2023
CBSM phone app eases anxiety, depression in cancer patients
Publish date: June 23, 2023
Huge underuse of germline testing for cancer patients
Publish date: June 22, 2023
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology
Publish date: June 15, 2023
Atorvastatin cut anthracycline cardiac dysfunction in lymphoma
Publish date: March 4, 2023
Patients with blood cancers underutilize palliative care
Publish date: June 23, 2022
Many patients, doctors unaware of advancements in cancer care
Publish date: October 4, 2021
Most community-based oncologists skip biomarker testing
Publish date: September 21, 2021
Experimental antibody-drug conjugate shown active against r/r DLBCL
Publish date: June 15, 2021
The power and promise of social media in oncology
Publish date: May 3, 2021

Prognostic factors of bladder cancer

Question 1 of 5

Which of the following factors is/are considered to be major prognostic factors in carcinoma of the bladder?

Choose one

	Depth of invasion into the bladder wall
	Pathologic grade of the tumor
	Presence versus absence of carcinoma in situ
	A and B
	A, B, and C

Highlighted from this site and network

Custom Programs

Editorial Policy

Medscape Customer Support

Frequently Asked Questions

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

FULL MENU FULL MENU

FULL MENU FULL MENU
More
- Federal Practitioner Home
- Digital Edition/App

Breast Cancer
Clinical Edge
Colon and Rectal
Education Center
Multiple Myeloma
Head & Neck Cancers
Hematology
Hospice & Palliative Medicine
Immuno-oncology
Leukemia, Myelodysplasia, Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
MD-IQ
Melanoma
Prostate Cancer
Rare Diseases
Special Issues

More

Federal Practitioner Home
Digital Edition/App